Your browser doesn't support javascript.
loading
Blood microbiota diversity determines response of advanced colorectal cancer to chemotherapy combined with adoptive T cell immunotherapy.
Yang, Duo; Wang, Xiaoli; Zhou, Xinna; Zhao, Jing; Yang, Huabing; Wang, Shuo; Morse, Michael A; Wu, Jiangping; Yuan, Yanhua; Li, Sha; Hobeika, Amy; Lyerly, Herbert Kim; Ren, Jun.
Afiliação
  • Yang D; Department of Therapeutic Cancer Vaccines and Medical OncologyBeijing Shijitan Hospital, Capital Medical University, Beijing Key Laboratory for Therapeutic Cancer Vaccines, Beijing, China.
  • Wang X; Department of Therapeutic Cancer Vaccines and Medical OncologyBeijing Shijitan Hospital, Capital Medical University, Beijing Key Laboratory for Therapeutic Cancer Vaccines, Beijing, China.
  • Zhou X; Department of Therapeutic Cancer Vaccines and Medical OncologyBeijing Shijitan Hospital, Capital Medical University, Beijing Key Laboratory for Therapeutic Cancer Vaccines, Beijing, China.
  • Zhao J; Department of Therapeutic Cancer Vaccines and Medical OncologyBeijing Shijitan Hospital, Capital Medical University, Beijing Key Laboratory for Therapeutic Cancer Vaccines, Beijing, China.
  • Yang H; Department of Medical Oncology, Fudan University Pudong Medical Center, Shanghai, China.
  • Wang S; Department of Therapeutic Cancer Vaccines and Medical OncologyBeijing Shijitan Hospital, Capital Medical University, Beijing Key Laboratory for Therapeutic Cancer Vaccines, Beijing, China.
  • Morse MA; Department of Surgery, Duke University Medical Center, Durham, NC, USA.
  • Wu J; Department of Therapeutic Cancer Vaccines and Medical OncologyBeijing Shijitan Hospital, Capital Medical University, Beijing Key Laboratory for Therapeutic Cancer Vaccines, Beijing, China.
  • Yuan Y; Department of Medical Oncology, Fudan University Pudong Medical Center, Shanghai, China.
  • Li S; Department of Therapeutic Cancer Vaccines and Medical OncologyBeijing Shijitan Hospital, Capital Medical University, Beijing Key Laboratory for Therapeutic Cancer Vaccines, Beijing, China.
  • Hobeika A; Department of Surgery, Duke University Medical Center, Durham, NC, USA.
  • Lyerly HK; Department of Surgery, Duke University Medical Center, Durham, NC, USA.
  • Ren J; Department of Medical Oncology, Fudan University Pudong Medical Center, Shanghai, China.
Oncoimmunology ; 10(1): 1976953, 2021.
Article em En | MEDLINE | ID: mdl-34595059
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Microbiota Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Oncoimmunology Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Microbiota Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Oncoimmunology Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China País de publicação: Estados Unidos